These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 37519201)

  • 1. Untangling breast cancer: Trailing towards nanoformulations-based drug development.
    Verma R; Kumar K; Bhatt S; Yadav M; Kumar M; Tagde P; Rajinikanth PS; Tiwari A; Tiwari V; Nagpal D; Mittal V; Kaushik D
    Recent Pat Nanotechnol; 2023 Jul; ():. PubMed ID: 37519201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging Nanotechnology-based Therapeutics: A New Insight into Promising Drug Delivery System for Lung Cancer Therapy.
    Verma R; Rao L; Nagpal D; Yadav M; Kumar V; Kumar V; Kumar H; Parashar J; Bansal N; Kumar M; Pandey P; Mittal V; Kaushik D
    Recent Pat Nanotechnol; 2024; 18(4):395-414. PubMed ID: 37537775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Clinical Translation of Organic Nanomaterials for Cancer Therapy: A Focus on Polymeric Nanoparticles, Micelles, Liposomes and Exosomes.
    Palazzolo S; Bayda S; Hadla M; Caligiuri I; Corona G; Toffoli G; Rizzolio F
    Curr Med Chem; 2018; 25(34):4224-4268. PubMed ID: 28875844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Applications of Nanomedicine in Brain Tumor Therapy: Nanocarrierbased Drug Delivery Platforms, CChallenges, and Perspectives.
    Verma R; Rao L; Kumar H; Bansal N; Deep A; Parashar J; Yadav M; Mittal V; Kaushik D
    Recent Pat Nanotechnol; 2023 Nov; ():. PubMed ID: 37937554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring the Prospective of Curcumin-loaded Nanomedicine in Brain Cancer Therapy: An Overview of Recent Updates and Patented Nanoformulations.
    Verma R; Rao L; Nagpal D; Yadav M; Kumar M; Mittal V; Kaushik D
    Recent Pat Nanotechnol; 2024; 18(3):278-294. PubMed ID: 37904561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perspectives in Breast and Ovarian Cancer Chemotherapy by Nanomedicine Approach: Nanoformulations in Clinical Research.
    Martín-Sabroso C; Fraguas-Sánchez AI; Raposo-González R; Torres-Suárez AI
    Curr Med Chem; 2021; 28(17):3271-3286. PubMed ID: 32814522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Organic Nanodelivery Systems as a New Platform in the Management of Breast Cancer: A Comprehensive Review from Preclinical to Clinical Studies.
    Rafik ST; Vaidya JS; MacRobert AJ; Yaghini E
    J Clin Med; 2023 Apr; 12(7):. PubMed ID: 37048731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multifunctional Patented Nanotherapeutics for Cancer Intervention: 2010- Onwards.
    Pandey P; Chopra H; Kaushik D; Verma R; Purohit D; Parashar J; Mittal V; Rahman MH; Bhatia S; Kumar P; Bhattacharya T; Tagde P; Al-Harrasi A
    Recent Pat Anticancer Drug Discov; 2023; 18(1):38-52. PubMed ID: 35319390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent progress of drug nanoformulations targeting to brain.
    Khan AR; Yang X; Fu M; Zhai G
    J Control Release; 2018 Dec; 291():37-64. PubMed ID: 30308256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of nanotechnology-based formulations in pediatric populations.
    Yellepeddi VK; Joseph A; Nance E
    Adv Drug Deliv Rev; 2019; 151-152():44-55. PubMed ID: 31494124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Curcumin Nanoformulations for Colorectal Cancer: A Review.
    Wong KE; Ngai SC; Chan KG; Lee LH; Goh BH; Chuah LH
    Front Pharmacol; 2019; 10():152. PubMed ID: 30890933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Herbal nanomedicines: Recent advancements, challenges, opportunities and regulatory overview.
    Teja PK; Mithiya J; Kate AS; Bairwa K; Chauthe SK
    Phytomedicine; 2022 Feb; 96():153890. PubMed ID: 35026510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanotechnology: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2006; 6(19):1-43. PubMed ID: 23074489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opportunities in combinational chemo-immunotherapy for breast cancer using nanotechnology: an emerging landscape.
    Raikwar S; Jain A; Saraf S; Bidla PD; Panda PK; Tiwari A; Verma A; Jain SK
    Expert Opin Drug Deliv; 2022 Mar; 19(3):247-268. PubMed ID: 35184620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanotechnological approaches for diagnosis and treatment of ovarian cancer: a review of recent trends.
    Ding H; Zhang J; Zhang F; Xu Y; Liang W; Yu Y
    Drug Deliv; 2022 Dec; 29(1):3218-3232. PubMed ID: 36259505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanomedicine-Based Drug-Targeting in Breast Cancer: Pharmacokinetics, Clinical Progress, and Challenges.
    Rahman M; Afzal O; Ullah SNMN; Alshahrani MY; Alkhathami AG; Altamimi ASA; Almujri SS; Almalki WH; Shorog EM; Alossaimi MA; Mandal AK; Abdulrahman A; Sahoo A
    ACS Omega; 2023 Dec; 8(51):48625-48649. PubMed ID: 38162753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progress in antiretroviral drug delivery using nanotechnology.
    Mallipeddi R; Rohan LC
    Int J Nanomedicine; 2010 Aug; 5():533-47. PubMed ID: 20957115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advanced drug delivery to the lymphatic system: lipid-based nanoformulations.
    Ali Khan A; Mudassir J; Mohtar N; Darwis Y
    Int J Nanomedicine; 2013; 8():2733-44. PubMed ID: 23926431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A review of nanotechnology-based approaches for breast cancer and triple-negative breast cancer.
    Jain V; Kumar H; Anod HV; Chand P; Gupta NV; Dey S; Kesharwani SS
    J Control Release; 2020 Oct; 326():628-647. PubMed ID: 32653502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.